UBS AM’s Oak Street Health, Inc. OSH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-219,783
| Closed | -$8.5M | – | 2756 |
|
|
2023
Q2 | $8.5M | Hold |
219,783
| – | – | ﹤0.01% | 1029 |
|
|
2023
Q1 | $8.5M | Sell |
219,783
-11,676
| -5% | -$377K | ﹤0.01% | 1029 |
|
|
2022
Q4 | $4.98M | Buy |
231,459
+10,741
| +5% | +$225K | ﹤0.01% | 1173 |
|
|
2022
Q3 | $5.41M | Buy |
220,718
+11,657
| +6% | +$308K | ﹤0.01% | 1173 |
|
|
2022
Q2 | $3.44M | Buy |
209,061
+26,020
| +14% | +$505K | ﹤0.01% | 1360 |
|
|
2022
Q1 | $4.92M | Sell |
183,041
-88,420
| -33% | -$1.86M | ﹤0.01% | 1359 |
|
|
2021
Q4 | $9M | Buy |
271,461
+33,876
| +14% | +$1.28M | ﹤0.01% | 1163 |
|
|
2021
Q3 | $10.1M | Buy |
237,585
+5,820
| +3% | +$313K | ﹤0.01% | 1093 |
|
|
2021
Q2 | $13.6M | Buy |
231,765
+201,532
| +667% | +$12M | 0.01% | 1002 |
|
|
2021
Q1 | $1.64M | Buy |
30,233
+26,108
| +633% | +$1.45M | ﹤0.01% | 1838 |
|
|
2020
Q4 | $252K | Buy |
+4,125
| New | +$216K | ﹤0.01% | 2451 |
|
UBS AM's OSH Position: Q3 2023 in Review
UBS AM sold out of Oak Street Health, Inc. (OSH) in Q3 2023, closing a stake of 219,783 shares — an estimated $8.5M sold.
UBS AM first reported a position in OSH in Q4 2020 and held it in 11 quarters. The position peaked at $13.6M in Q2 2021. 0 funds tracked by Wall St. Rank hold OSH as of Q3 2023.
- UBS AM reported no remaining Oak Street Health, Inc. position as of Q3 2023 after selling out during the quarter.
- UBS AM sold 219,783 Oak Street Health, Inc. shares in Q3 2023, an estimated $8.5M.
- UBS AM first reported a position in Oak Street Health, Inc. in Q4 2020 and held it in 11 quarters.
- UBS AM's Oak Street Health, Inc. position peaked at $13.6M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q3 2023.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.